Cost-effectiveness and budget impact of adjunctive... (2008 study) Skip to main content
Review International journal of technology assessment in health care 2008 Canadian

Cost-effectiveness and budget impact of adjunctive hyperbaric oxygen therapy for diabetic foot ulcers.

Chuck AW, Hailey D, Jacobs P, Perry DC, International journal of technology assessment in health care, 2008

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers built a decision model to compare the cost and health outcomes of adding hyperbaric oxygen therapy (HBOT) to standard care versus standard care alone for diabetic foot ulcers in Canada.

What They Found

This Canadian cost-effectiveness modelling review estimated that adding HBOT to standard care for diabetic foot ulcers cost CND$40,695 per patient over 12 years versus CND$49,786 for standard care alone, with 3.64 versus 3.01 quality-adjusted life-years. The model used a 65-year-old cohort and a Ministry of Health perspective. Its efficacy inputs came from studies in a literature review, so the results depend on those studies and on the model's assumptions. Treating all prevalent cases in Canada was estimated at CND$14.4-19.7 million per year over 4 years. If seven-person chambers were used, nineteen to thirty-five more machines would be needed nationally. The authors concluded that adjunctive HBOT is cost-effective compared with standard care and that extra capacity would be needed if it became the standard of care across Canada.

What This Means for Canadian Patients

For people with diabetic foot ulcers, this study suggests that, in its model, adding HBOT to standard care lowered long-term costs and gave more quality-adjusted life-years. It is an economic projection, not a trial of patients, and it does not report individual treatment results. The abstract also says wider use would need more chambers, so access could depend on capacity.

Canadian Relevance

The study was done as part of a Canadian assessment and used Canadian cost and utilization data from government records. The authors modelled costs from a Ministry of Health perspective.

Study Limitations

The findings come from a model that relies on efficacy data taken from other studies and on assumptions about a hypothetical 65-year-old cohort, so real-world costs and outcomes could differ.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Wound Care
Source Pubmed
PubMed ID 18400121
Year Published 2008
Journal International journal of technology assessment in health care
MeSH Terms Aged; Amputation, Surgical; Cost-Benefit Analysis; Decision Support Techniques; Diabetic Foot; Humans; Hyperbaric Oxygenation; Models, Econometric; Quality-Adjusted Life Years; Technology Assessment, Biomedical

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology